UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Hereditary angioedema (HAE) in children and adolescents—a consensus on therapeutic strategies

European journal of pediatrics, 2012-09, Vol.171 (9), p.1339-1348

2012

Volltextzugriff (PDF)

Rate of inhibitor development in previously untreated hemophilia A patients treated with plasma‐derived or recombinant factor VIII concentrates: a systematic review

Journal of thrombosis and haemostasis, 2010-06, Vol.8 (6), p.1256-1265

2010

Volltextzugriff (PDF)

Risk of angioedema following invasive or surgical procedures in HAE type I and II – the natural history

Allergy (Copenhagen), 2013-08, Vol.68 (8), p.1034-1039

2013

Volltextzugriff (PDF)

Prophylaxis with FEIBA in paediatric patients with haemophilia A and inhibitors

Haemophilia : the official journal of the World Federation of Hemophilia, 2015-05, Vol.21 (3), p.358-364

2015

Volltextzugriff (PDF)

Characterization of prodromal symptoms in a large population of patients with hereditary angio-oedema

Clinical and experimental dermatology, 2014-04, Vol.39 (3), p.298-303

2014

Volltextzugriff (PDF)

A review of immune tolerance induction with Haemate® P in haemophilia A

Haemophilia : the official journal of the World Federation of Hemophilia, 2014-05, Vol.20 (3), p.333-339

2014

Volltextzugriff (PDF)

The immune tolerance induction (ITI) dose debate: does the International ITI Study provide a clearer picture?

Haemophilia : the official journal of the World Federation of Hemophilia, 2013-01, Vol.19 (s1), p.12-17

2013

Volltextzugriff (PDF)

Early long-term FEIBA prophylaxis in haemophilia A patients with inhibitor after failing immune tolerance induction: A prospective clinical case series

Haemophilia : the official journal of the World Federation of Hemophilia, 2010-01, Vol.16 (1), p.90-100

2010

Volltextzugriff (PDF)

First prospective report on immune tolerance in poor risk haemophilia A inhibitor patients with a single factor VIII/von Willebrand factor concentrate in an observational immune tolerance induction study

Haemophilia : the official journal of the World Federation of Hemophilia, 2016-01, Vol.22 (1), p.87-95

2016

Volltextzugriff (PDF)

von Willebrand's disease: from discovery to therapy - milestones in the last 25 years

Haemophilia : the official journal of the World Federation of Hemophilia, 2008-11, Vol.14 (s5), p.1-2

KREUZ, W.

2008

Volltextzugriff (PDF)

Risk of recurrent venous thrombosis in children with combined prothrombotic risk factors

Blood, 2001-02, Vol.97 (4), p.858-862

2001

Volltextzugriff (PDF)

Recombinant vs. plasma-derived products, especially those with intact VWF, regarding inhibitor development

Haemophilia : the official journal of the World Federation of Hemophilia, 2006-12, Vol.12 (s6), p.102-106

2006

Volltextzugriff (PDF)

Haemate® P/Humate-P® for the treatment of von Willebrand disease: considerations for use and clinical experience

Haemophilia : the official journal of the World Federation of Hemophilia, 2008-11, Vol.14 (s5), p.39-46

2008

Volltextzugriff (PDF)

Review of the Long-Term Safety of a Human Pasteurized C1 Inhibitor Concentrate

Journal of allergy and clinical immunology, 2012-02, Vol.129 (2), p.AB222-AB222

2012

Volltextzugriff (PDF)

Minor head injury as cause and co-factor in the aetiology of stroke in childhood: a report of eight cases

Journal of neurology, neurosurgery and psychiatry, 2002-07, Vol.73 (1), p.13-16

2002

Volltextzugriff (PDF)

Mutational spectrum of the C1INH (SERPING1) gene in patients with hereditary angioedema

Cytogenetic and genome research, 2008-08, Vol.121 (3-4), p.181-188

2008

Volltextzugriff (PDF)

Management of paediatric patients with Hereditary Angioedema (HAE)- A retrospective evaluation of 120 patients from 91 families

Journal of allergy and clinical immunology, 2012-02, Vol.129 (2), p.AB221-AB221

2012

Volltextzugriff (PDF)

Pregnancies in Women with Hereditary Angioedema due to Mutations in the F12 gene

Journal of allergy and clinical immunology, 2012-02, Vol.129 (2), p.AB80-AB80

2012

Volltextzugriff (PDF)

Symptomatic onset of severe hemophilia A in childhood is dependent on the presence of prothrombotic risk factors

Thrombosis and haemostasis, 2001-02, Vol.85 (2), p.218-200

2001

Volltextzugriff (PDF)

Risk of Angioedema following operative and invasive Procedures in Hereditary Angioedema due to C1-inhibitor Deficiency

Journal of allergy and clinical immunology, 2011-02, Vol.127 (2), p.AB266-AB266

2011

Volltextzugriff (PDF)

A common 253‐kb deletion involving VWF and TMEM16B in German and Italian patients with severe von Willebrand disease type 3

Journal of thrombosis and haemostasis, 2007-04, Vol.5 (4), p.722-728

2007

Volltextzugriff (PDF)

multi-centre study of efficacy and safety of Intratect®, a novel intravenous immunoglobulin preparation

Clinical and experimental immunology, 2010-09, Vol.161 (3), p.512-517

2010

Volltextzugriff (PDF)

Pharmacokinetic Berinert P Study Of Subcutaneous Versus Intravenous Administration In Subjects With Moderate Hereditary Angioedema - The Passion Study

Journal of allergy and clinical immunology, 2011-02, Vol.127 (2), p.AB104-AB104

2011

Volltextzugriff (PDF)

Idiopathic Angioedema and Coagulation Factor XII Mutation

Journal of allergy and clinical immunology, 2011-02, Vol.127 (2), p.AB99-AB99

2011

Volltextzugriff (PDF)

Immune tolerance induction with a factor VIII concentrate containing von Willebrand factor (Haemoctin SDH®) in 14 patients with severe haemophilia A

Haemophilia : the official journal of the World Federation of Hemophilia, 2011-09, Vol.17 (5), p.e837-e840

2011

Volltextzugriff (PDF)

1 – 25 von 351

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(302)
Mit Volltextzugriff
(276)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Hereditary angioedema (HAE) in children and adolescents—a consensus on therapeutic strategies

Rate of inhibitor development in previously untreated hemophilia A patients treated with plasma‐derived or recombinant factor VIII concentrates: a systematic review

Risk of angioedema following invasive or surgical procedures in HAE type I and II – the natural history

Prophylaxis with FEIBA in paediatric patients with haemophilia A and inhibitors

Characterization of prodromal symptoms in a large population of patients with hereditary angio-oedema

A review of immune tolerance induction with Haemate® P in haemophilia A

The immune tolerance induction (ITI) dose debate: does the International ITI Study provide a clearer picture?

Early long-term FEIBA prophylaxis in haemophilia A patients with inhibitor after failing immune tolerance induction: A prospective clinical case series

First prospective report on immune tolerance in poor risk haemophilia A inhibitor patients with a single factor VIII/von Willebrand factor concentrate in an observational immune tolerance induction study

von Willebrand's disease: from discovery to therapy - milestones in the last 25 years

Risk of recurrent venous thrombosis in children with combined prothrombotic risk factors

Recombinant vs. plasma-derived products, especially those with intact VWF, regarding inhibitor development

Haemate® P/Humate-P® for the treatment of von Willebrand disease: considerations for use and clinical experience

Review of the Long-Term Safety of a Human Pasteurized C1 Inhibitor Concentrate

Minor head injury as cause and co-factor in the aetiology of stroke in childhood: a report of eight cases

Mutational spectrum of the C1INH (SERPING1) gene in patients with hereditary angioedema

Management of paediatric patients with Hereditary Angioedema (HAE)- A retrospective evaluation of 120 patients from 91 families

Pregnancies in Women with Hereditary Angioedema due to Mutations in the F12 gene

Symptomatic onset of severe hemophilia A in childhood is dependent on the presence of prothrombotic risk factors

Risk of Angioedema following operative and invasive Procedures in Hereditary Angioedema due to C1-inhibitor Deficiency

A common 253‐kb deletion involving VWF and TMEM16B in German and Italian patients with severe von Willebrand disease type 3

multi-centre study of efficacy and safety of Intratect®, a novel intravenous immunoglobulin preparation

Pharmacokinetic Berinert P Study Of Subcutaneous Versus Intravenous Administration In Subjects With Moderate Hereditary Angioedema - The Passion Study

Idiopathic Angioedema and Coagulation Factor XII Mutation

Immune tolerance induction with a factor VIII concentrate containing von Willebrand factor (Haemoctin SDH®) in 14 patients with severe haemophilia A

Suchergebnisse filtern